Published in Ann Intern Med on April 15, 1998
Non-surgical treatment of esophageal achalasia. World J Gastroenterol (2006) 0.81
HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol (1998) 3.05
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis (2001) 2.30
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations. Aliment Pharmacol Ther (2012) 2.28
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28
Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol (1996) 2.01
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy (2010) 1.89
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86
Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol (2005) 1.85
Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther (2000) 1.73
Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut (2009) 1.65
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62
Detection of abnormal lesions recorded by capsule endoscopy. A prospective study comparing endoscopist's and nurse's accuracy. Dig Liver Dis (2006) 1.61
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1998) 1.60
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis (2005) 1.57
Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC) Ital J Gastroenterol Hepatol (1997) 1.53
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Dig Liver Dis (2007) 1.43
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol (1999) 1.42
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39
Microscopic colitis progressed to collagenous colitis: a morphometric study. Ital J Gastroenterol (1996) 1.39
Aminopyrine breath test. Dig Dis Sci (1994) 1.39
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther (2006) 1.29
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol (2006) 1.18
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol (2001) 1.17
Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol (1997) 1.17
The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (1997) 1.16
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther (2001) 1.14
HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol (1999) 1.13
IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine (2004) 1.13
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol (2001) 1.13
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol (1998) 1.12
Treatment of antibiotic-resistant Helicobacter pylori. N Engl J Med (1998) 1.11
13C-octanoic acid breath test: a reliable tool for measuring gastric emptying. Ital J Gastroenterol Hepatol (1998) 1.10
Characteristics of hepatocellular carcinoma in Italy. J Hepatol (1998) 1.08
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int (2011) 1.08
Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther (1998) 1.08
Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet (2001) 1.05
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther (2002) 1.04
Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut (2004) 1.03
Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine (2005) 1.03
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology (1999) 1.01
The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest (1998) 1.01
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis (2011) 1.00
Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial. Surg Endosc (2004) 1.00
Helicobacter pylori infection may undergo spontaneous eradication in children: a 2-year follow-up study. J Pediatr Gastroenterol Nutr (1998) 0.99
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther (2006) 0.99
An optimized experimental protocol based on neuro-evolutionary algorithms application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment. Artif Intell Med (2005) 0.97
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther (2003) 0.97
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther (2013) 0.97
Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol (2009) 0.95
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis. Dig Dis Sci (1999) 0.94
Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc (1996) 0.94
Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients. Aliment Pharmacol Ther (2009) 0.94
13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol (2000) 0.93
13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci (2004) 0.92
Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology (1999) 0.92
Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol (1999) 0.92
Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther (2004) 0.91
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol (1995) 0.91
MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes Immun (2008) 0.90
Serum immunoreactive cationic trypsinogen response to secretin in normal subjects. Am J Gastroenterol (1983) 0.90
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther (2005) 0.90
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Aliment Pharmacol Ther (2007) 0.90
Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther (2005) 0.90
Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study. Aliment Pharmacol Ther (2006) 0.90
Gross pathologic types of hepatocellular carcinoma in Italy. Oncology (1999) 0.89
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. Dig Liver Dis (2005) 0.89
The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2007) 0.89
Review article: pharmacological options in achalasia. Aliment Pharmacol Ther (1999) 0.89
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. Aliment Pharmacol Ther (1997) 0.89
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin. Aliment Pharmacol Ther (2010) 0.88
HCV genotypes in patients with liver disease of different stages and severity. J Hepatol (1997) 0.88
HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol (1998) 0.88
The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. Gastroenterology (1999) 0.87
Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol (1999) 0.87
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. J Viral Hepat (2005) 0.87
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther (2003) 0.87
The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Am J Gastroenterol (2010) 0.86
Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Dis Colon Rectum (1998) 0.86